Ratings by BMO Capital
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | Evan Seigerman | Eli Lilly | LLY | Maintain | Outperform (N/A) |
1,400.00 (N/A) |
|
Details | |
| 9/1/2026 | Phillip Jungwirth | SLB | SLB | Maintain | Outperform (N/A) |
62.00 (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 16,418 more... | |||||||||
